参考文献/References:
[1] ESC Scientific Document Group. [2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death][J]. G Ital Cardiol (Rome),2023,24(3 suppl 1):e1-e132.
[2] Al-Khatib SM,Stevenson WG,Ackerman MJ,et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death:executive summary:a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society[J]. Heart Rhythm,2018,15(10):e190-e252.
[3] Wissner E,Stevenson WG,Kuck KH. Catheter ablation of ventricular tachycardia in ischaemic and non-ischaemic cardiomyopathy:where are we today? A clinical review[J]. Eur Heart J,2012,33(12):1440-1450.
[4] Baldinger SH,Stevenson WG,John RM. Ablation of ischemic ventricular tachycardia:evidence,techniques,results,and future directions[J]. Curr Opin Cardiol,2016,31(1):29-36.
[5] Cronin EM,Bogun FM,Maury P,et al. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias[J]. Europace,21(8):1143-1144.
[6] Miller JM,Marchlinski FE,Harken AH,et al. Subendocardial resection for sustained ventricular tachycardia in the early period after acute myocardial infarction[J]. Am J Cardiol,1985,55(8):980-984.
[7] Yousuf OK,Zusterzeel R,Sanders W,et al. Trends and outcomes of catheter ablation for ventricular tachycardia in a community cohort[J]. JACC Clin Electrophysiol,2018,4(9):1189-1199.
[8] Siontis KC,Jamé S,Sharaf Dabbagh G,et al. Thromboembolic prophylaxis protocol with warfarin after radiofrequency catheter ablation of infarct-related ventricular tachycardia.[J]. J Cardiovasc Electrophysiol,2018,29(4):584-590.
[9] Tung R,Vaseghi M,Frankel DS,et al. Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease:an International VT Ablation Center Collaborative Group study[J]. Heart Rhythm,2015,12(9):1997-2007.
[10] Peichl P,Wichterle D,Pavlu L,et al. Complications of catheter ablation of ventricular tachycardia:a single-center experience[J]. Circ Arrhythm Electrophysiol,2014,7(4):684-690.
[11] Bohnen M,Stevenson WG,Tedrow UB,et al. Incidence and predictors of major complications from contemporary catheter ablation to treat cardiac arrhythmias[J]. Heart Rhythm,2011,8(11):1661-1666.
[12] Deyell MW,AbdelWahab A,Angaran P,et al. 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society position statement on the management of ventricular tachycardia and fibrillation in patients with structural heart disease[J]. Can J Cardiol,2020,36(6):822-836.
[13] Sticherling C,Marin F,Birnie D,et al. Antithrombotic management in patients undergoing electrophysiological procedures:a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis,Heart Rhythm Society (HRS),and Asia Pacific Heart Rhythm Society (APHRS)[J]. Europace,2015,17(8):1197-1214.
[14] Shivkumar K. Catheter ablation of ventricular arrhythmias[J]. N Engl J Med,2019,380(16):1555-1564.
[15] Wright M,Harks E,Deladi S,et al. Visualizing intramyocardial steam formation with a radiofrequency ablation catheter incorporating near-field ultrasound[J]. J Cardiovasc Electrophysiol,2013,24(12):1403-1409.
[16] Seiler J,Roberts-Thomson KC,Raymond JM,et al. Steam pops during irrigated radiofrequency ablation:feasibility of impedance monitoring for prevention[J]. Heart Rhythm,2008,5(10):1411-1416.
[17] Mallidi J,Nadkarni GN,Berger RD,et al. Meta-analysis of catheter ablation as an adjunct to medical therapy for treatment of ventricular tachycardia in patients with structural heart disease[J]. Heart Rhythm,2011,8(4):503-510.
[18] Gaita F,Caponi D,Pianelli M,et al. Radiofrequency catheter ablation of atrial fibrillation:a cause of silent thromboembolism? Magnetic resonance imaging assessment of cerebral thromboembolism in patients undergoing ablation of atrial fibrillation[J]. Circulation,2010,122(17):1667-1673.
[19] Whitman IR,Gladstone RA,Badhwar N,et al. Brain emboli after left ventricular endocardial ablation[J]. Circulation,2017,135(9):867-877.
[20] Zei PC,Vora N. The sound of silence:how much noise should we make about postablation silent strokes?[J]. Circulation,2017,135(9):878-880.
[21] di Biase L,Lakkireddy DJ,Marazzato J,et al. Antithrombotic therapy for patients?undergoing cardiac electrophysiological and interventional?procedures:JACC state-of-the-art review[J]. J Am Coll Cardiol,2024,83(1):82-108.
[22] Lakkireddy D,Shenthar J,Garg J,et al. Safety/efficacy of DOAC versus aspirin for reduction of risk of cerebrovascular events following VT ablation[J]. JACC:Clinical Electrophysiology,2021,7(12):1493-1501.
[23] Deshmukh A,Gunda S,Siontis KC,et al. Comparison of warfarin with direct oral anticoagulants for thromboembolic prophylaxis after catheter ablation of ventricular tachycardia.[J]. J Cardiovasc Electrophysiol,2023,34(4):967-972.
[24] Yanagisawa S,Inden Y,Riku S,et al. Coagulation response and prothrombotic effect of uninterrupted oral anticoagulant administration after?catheter ablation for VT[J]. JACC Clin Electrophysiol,2022,8(6):735-748.
[25] Romero JE,Goldhaber SZ. Uninterrupted oral anticoagulation during catheter ablation of ventricular?tachycardia:is the riskier option the safest?[J]. JACC Clin Electrophysiol,2022,8(6):749-753.
[26] Konishi H,Suzuki A,Hohmann S,et al. Comparison of microemboli formation between irrigated catheter tip architecture using a microemboli monitoring system[J]. JACC Clin Electrophysiol,2022,8(1):26-37.
[27] Heeger CH,Metzner A,Schlüter M,et al. Cerebral protection during catheter ablation of ventricular tachycardia in patients with ischemic heart disease[J]. J Am Heart Assoc,2018,7(13):e009005.
[28] Reddy VY,Koruth J,Jais P,et al. Ablation of atrial fibrillation with pulsed?electric fields:an ultra-rapid,tissue-selective modality for cardiac ablation[J]. JACC Clin Electrophysiol,2018,4(8):987-995.
[29] Koruth JS,Kuroki K,Iwasawa J,et al. Endocardial ventricular pulsed field ablation:a proof-of-concept preclinical evaluation[J]. Europace,2020,22(3):434-439.
[30] Siontis KC,Killu AM. Silent and non‐silent thromboembolic events after ventricular tachycardia ablation:Modifiable risk with postprocedure anticoagulation?[J]. J Cardiovasc Electrophysiol,2019,30(8):1197-1199.
[31] Perucki WH,Smietana JJ,Cronin EM,et al. Does anticoagulation belie the emboli?[J]. JACC Clin Electrophysiol,2022,8(2):258-259.
[32] Cuculich PS,Schill MR,Kashani R,et al. Noninvasive cardiac radiation for ablation of ventricular tachycardia[J]. N Engl J Med,2017,377(24):2325-2336.
[33] Vissing CR,Axelsson Raja A,Day SM,et al. Cardiac remodeling in subclinical hypertrophic cardiomyopathy:the VANISH randomized clinical trial[J]. JAMA Cardiol,2023,8(11):1083-1088.
[34] Tung R,Vaseghi M,Frankel DS,et al. Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease:an International VT Ablation Center Collaborative Group study[J]. Heart Rhythm,2015,12(9):1997-2007.
相似文献/References:
[1]马丽 黄从新.心房颤动患者导管消融术后早期复发的机制及处理[J].心血管病学进展,2019,(5):762.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.024]
MA LiHUANG Congxin.The Machanism and the Therapy of Early Recurrence after Catheter Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2019,(8):762.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.024]
[2]解忠慧 崔凯军.心房颤动转子标测与消融的研究进展[J].心血管病学进展,2019,(8):1078.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.002]
XIE Zhonghui,CUI Kaijun.Rotors Ablation in Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2019,(8):1078.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.002]
[3]李才垚 王洪涛 秦兴华 刘鹏 郑强荪.心肌梗死后室性心动过速导管消融适应证在指南共识中的演变[J].心血管病学进展,2021,(5):421.[doi:10.16806/j.cnki.issn.1004-3934.2021.05.009]
LI Caiyao,WANG Hongtao,QIN Xinghua,et al.Evolution of Indications for Ablation of Ventricular Tachycardia after Myocardial Infarction in Guidelines and Consensus[J].Advances in Cardiovascular Diseases,2021,(8):421.[doi:10.16806/j.cnki.issn.1004-3934.2021.05.009]
[4]王思博 王连生.心肌梗死后室性心律失常的治疗进展[J].心血管病学进展,2021,(6):481.[doi:10.16806/j.cnki.issn.1004-3934.2021.06.001]
WANG SiboWANG Liansheng.Treatment of Ventricular Arrhythmias after Myocardial Infarction[J].Advances in Cardiovascular Diseases,2021,(8):481.[doi:10.16806/j.cnki.issn.1004-3934.2021.06.001]
[5]赵海娟 李珂 赵耀 彭玉霞 黄松群 郭志福.成人先天性心脏病合并心房颤动的诊治进展[J].心血管病学进展,2023,(3):216.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.006]
ZHAO Haijuan,LI Ke,ZHAO Yao,et al.Atrial Fibrillation in Congenital Heart Disease[J].Advances in Cardiovascular Diseases,2023,(8):216.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.006]
[6]黄吉凤 何永铭.非缺血性心肌病室性心动过速导管消融的研究进展[J].心血管病学进展,2023,(5):430.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.011]
HUANG Jifeng,HE Yongming.Catheter Ablation of Ventricular Tachycardia in Non-ischemic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2023,(8):430.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.011]
[7]王芯梦 崔凯军.心脏磁共振成像在室性心动过速消融治疗中的应用进展[J].心血管病学进展,2024,(1):48.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.013]
WANG Xinmeng,CUI Kaijun.Cardiac Magnetic Resonance Applied in Ablation of Ventricular Tachycardia[J].Advances in Cardiovascular Diseases,2024,(8):48.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.013]